Individualised Versus Conventional Medical Follow-up for Women After Primary Treatment for Ovarian Cancer.
A Randomised Study Comparing Satisfaction With Individualised Follow-up Led by a Trained Cancer Nurse Versus Conventional Medical Follow-up After Primary Treatment for Ovarian Cancer.
Sponsor: Mid and South Essex NHS Foundation Trust
This NA trial investigates Ovarian Cancer and is currently completed. Mid and South Essex NHS Foundation Trust leads this study, which shows 5 recorded versions since 2006 — indicating limited longitudinal coverage. As an oncology study, it adds to the longitudinal record of treatment development for this indication.
Status Flow
Change History
5 versions recorded-
Sep 2024 — Present [monthly]
Completed NA
-
Jul 2024 — Sep 2024 [monthly]
Completed NA
-
Jan 2021 — Jul 2024 [monthly]
Completed NA
-
Jun 2018 — Jan 2021 [monthly]
Completed NA
-
Jan 2017 — Jun 2018 [monthly]
Completed NA
First recorded
Jan 2006
Trial started
Per CT.gov start date — pre-dates our first snapshot
Eligibility Summary
No eligibility information available.
Contact Information
- Mid and South Essex NHS Foundation Trust
- University College London Hospitals
- University College, London
For direct contact, visit the study record on ClinicalTrials.gov .